First US Patients to be treated with SCENESSE; US insurance companies initiate coverage of SCENESSE® f or the first American patients diagnosed with erythropoietic protoporphyria (EPP)
http://www.asx.com.au/asxpdf/20200416/pdf/44gzrwnhjckpzs.pdf
Al these Shorters Lol
This is a Stock with Which you can -EARLIER- SAVE your RETIREMENT!!!
(if I wouldn't have "already")
News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-111
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.00 |
Change
0.040(0.29%) |
Mkt cap ! $701.0M | |||
| Open | High | Low | Value | Volume |
| $14.10 | $14.20 | $13.97 | $452.4K | 32.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 126 | $14.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.12 | 66 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |